Rafferty Asset Management’s Cidara Therapeutics CDTX Stock Holding History

Rafferty Asset Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,492	Closed	-$5.85M	–	1075
2025 Q4	$5.85M	Sell	26,492 -4,979	-16%	-$805K	0.02%	388
2025 Q3	$3.01M	Buy	+31,471	New	+$2.01M	0.01%	548

Rafferty Asset Management's CDTX Position: Q1 2026 in Review

Rafferty Asset Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 26,492 shares — an estimated $5.85M sold.

Rafferty Asset Management first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $5.85M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Rafferty Asset Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Rafferty Asset Management sold 26,492 Cidara Therapeutics shares in Q1 2026, an estimated $5.85M.
Rafferty Asset Management first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Rafferty Asset Management's Cidara Therapeutics position peaked at $5.85M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.